Evidence map›Paper›PMID 40105065›Full record

Trial reportEuropean journal of orthodontics2025

Long-term comparison of maxillary protraction with hybrid hyrax-facemask vs. hybrid hyrax-mentoplate protocols using Alt-RAMEC: a 5-year randomized controlled trial.

Joeri Meyns, Jeroen Meewis, Flore Dons, Arnoud Schreurs, Johan Aerts, Sohaib Shujaat, Constaninus Politis, Reinhilde Jacobs

Registry-linked trialAbstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in European journal of orthodontics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02711111 (Effect of Bone-anchored Protraction on Maxillary Growth in the Young Child), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02711111 naunknown statusnot on this map

Effect of Bone-anchored Protraction on Maxillary Growth in the Young Child

TypeinterventionalSponsorZiekenhuis Oost-LimburgRan2016 to 2021Enrolled20ConditionsMaxillary Hypoplasia, Malocclusion, Angle Class IIIArmsFace mask, orthodontic bone anchor
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joeri MeynsDepartment of Oral and Maxillofacial surgery, General Hospital St-Jan, Synaps park 1, 3600 Genk, Belgium.ORCID 0000-0002-8702-6144
Jeroen MeewisDepartment of Oral and Maxillofacial surgery, General Hospital St-Jan, Synaps park 1, 3600 Genk, Belgium.
Flore DonsDepartment of Oral and Maxillofacial surgery, General Hospital St-Jan, Synaps park 1, 3600 Genk, Belgium.
Arnoud SchreursPrivate Practice, Weg naar As 172/1, 3600 Genk, Belgium.
Johan AertsPrivate Practice, Collegelaan 12, 3600 Genk, Belgium.
Sohaib ShujaatDepartment of Imaging and Pathology, OMFS-IMPATH Research Group, Faculty of Medicine KU Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium.
Constaninus PolitisDepartment of Imaging and Pathology, OMFS-IMPATH Research Group, Faculty of Medicine KU Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium.
Reinhilde JacobsDepartment of Imaging and Pathology, OMFS-IMPATH Research Group, Faculty of Medicine KU Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study aimed to compare the short- and long-term effectiveness of hybrid Hyrax (HH) -Facemask (FM) and HH-mentoplate (MP) treatment protocols for maxillary protraction using Alt-RAMEC.

methodsA single-center 2-arm parallel randomized controlled trial. Participants: 28 skeletal class III patients (female: 14, male: 14; average age: 9.7 ± 1.3 years;) were included. Interventions: Two treatment groups where protraction therapy was combined with Alt-RAMEC. Group 1: Facemask group (Hybrid Hyrax + Facemask) and Group 2: Mentoplate group (Hybrid Hyrax + Mentoplate). Objective: To compare skeletal and dental changes between groups using low dose computed tomography (CT) scan from which virtual lateral cephalograms were generated. Outcome: Outcomes include changes in Wits appraisal (primary outcome), and cephalometric analysis of skeletal and dental changes (secondary outcomes) at 1 year and 5 years after treatment initiation. Randomization: 28 patients were allocated to either treatment-protocols using sequentially numbered opaque, sealed envelopes. The randomization sequence was generated with a 1:1 allocation ratio. Blinding: Due to the nature of the trial, the operator and children could not be blinded to the treatment allocation. However, blinding was used when assessing the outcomes.

resultsFollow-up: one patient was lost at the one-year follow-up and an additional three patients were lost at the 5-year follow-up. Outcomes: Both treatment protocols effectively improved intermaxillary relationship. Wits measurements showed improvements of 4.42 mm (FM) and 2.86 mm (MP) at T1, decreasing slightly to 3.33 mm (FM) and 1.50 mm (MP) at T2. While vertical control and incisor inclination were comparable between groups long-term, short-term differences were noted in upper and lower incisor inclination. Results remained equally stable after five years (T2). Harms: minor harms were encountered with the anchor hooks (fracture or mucosal irritation), however none led to treatment cessation.

conclusionsEarly class III treatment with HH + MP provided similar outcomes and stability to that of HH + FM suggesting that the choice between FM and MP should be based on individual patient factors rather than presumed mechanical advantages.

trial registrationClinical Trials ID: NCT02711111.

Indexed as

Extraoral Traction AppliancesMalocclusion, Angle Class IIIOrthodontic Appliance DesignCephalometryChildFemaleHumansMaleMaxillaPalatal Expansion TechniqueTomography, X-Ray ComputedTreatment Outcomebone anchoredfacemaskmaxillofacial protractionorthodonticsorthopedic therapyskeletal class III malocclusion

Identifiers

PMID40105065
PMCPMC11920792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.